Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...
Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Roche (RHHBY) announced that the Food and Drug Administration has approved Susvimo 100 mg/mL for the treatment of diabetic macular edema, a leading cause of vision loss in adults with diabetes ...
Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF290.00. The company’s shares closed yesterday at $316.42.
Sales in Roche’s pharmaceutical division grew 8% to CHF 46.2bn ($50.9bn). Credit: hapabapa via Getty Images. Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), ...
Roche Pharma India has appointed Rajwinder (Rajji) Mehdwan as country general manager, effective 1st April, 2025. She will also join the CEETRIS (Central Eastern Europe, Turkey, Russia & Indian ...
Roche Holding expects sales and core earnings to keep growing this year after beating analysts' expectations for 2024. The Swiss pharmaceutical giant is forecasting sales growth in the mid-single ...
Roche ROG2.09%increase; green up pointing triangle Holding expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024. The Swiss pharmaceutical giant ...
Roche Holding expects growth in sales and core earnings this year after beating analysts' expectations in 2024. The Swiss pharmaceutical giant said Thursday that for 2025 it expects sales growth ...
Inc, Sunovion Pharm. Inc, Suven pharmaceutical company, Roche pharmaceutical company, Biogen pharmaceutical company, Synexus clinical research organization and tauX pharmaceutical company and ...